Prevalence of NRG1 Fusions in Lung Cancer

Commentary
Video

D. Ross Camidge, MD, PhD, of University of Colorado Health Lung Cancer Clinic – Anschutz Medical Campus, discusses the prevalence of NRG1 fusions in lung cancer.

Related Videos
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer
Millie Das, MD
A panel of 5 experts on lung cancer
A panel of 5 experts on lung cancer
D. Ross Camidge, MD, PhD
D. Ross Camidge, MD, PhD
D. Ross Camidge, MD, PhD
Stephen V. Liu, MD
A panel of 5 experts on lung cancer
Related Content
Lung Cancer | Image Credit: © Axel Kock - stock.adobe.com

When Lung Cancer Took One Lung and COVID Took the Other, a Chicago Police Captain Was Left With Only One Option for Survival

May 16th 2024
Article
Hari B. Keshava, MD

Keshava Emphasizes the Importance of Lung Nodule Programs for Early Lung Cancer Detection

October 23rd 2023
Podcast
Anne Chiang, MD, PhD, of Yale School of Medicine

Applying the Heterogeneous Approach From NSCLC to SCLC

May 14th 2024
Article
Adnan F. Danish, MD

Danish Discusses the Benefits of SCINTIX Biology-Guided Radiotherapy in Metastatic Lung and Bone Cancers

August 7th 2023
Podcast
Shun Lu, MD, PhD

Repotrectinib Receives NMPA Approval in China for ROS1+ NSCLC

May 13th 2024
Article
Lung Cancer

Nivolumab/Chemoradiotherapy Regimen Misses PFS End Point in Unresectable, Locally Advanced NSCLC

May 10th 2024
Article